In a previous study we found higher fasting glucagon in individuals with obesity compared to controls with normal weight to be significantly associated with higher insulin, free fatty acids, triglycerides and visceral adipose tissue (VAT) (47). The gene discussed is INS; the disease is obesity disorder.